The Idolbuster

OCTOBER 5, 2012

It’s about making money for the company, and working with other people towards a common goal. The customers were almost all of the top twenty pharmaceutical companies, which reinforced her perception that the company was helping to revolutionize drug discovery.

Technology 38

Technology Bureaucracy Pharmaceuticals Loyalty 38

N2Growth Blog

FEBRUARY 4, 2015

Here is the rub and the reason why adopting this principle is so critical: in our experience, the priority initiatives turn out to be on new product, service, customer, and technology initiatives accompanied by an assumption that the organization has the capabilities to execute them.

Process 150

Process Agility Competitive Advantage Strategy 150

Marshall Goldsmith

FEBRUARY 8, 2018

Authority on new technology and communication. Former HR director with Pepsi Central Eastern Europe, and gained HR expertise at PLIVA Pharmaceutical Company (now part of Teva Group). Formerly in sales and sales management for pharmaceutical organizations including GlaxoSmithKline UK and US. Faculty of Columbia Business School.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas.

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

DECEMBER 20, 2011

The iPhone 4S's story seems to be about a new beginning: the highly anticipated launch of the latest version of a blockbuster consumer-technology product. Throughout its history, Pfizer's biggest product and the biggest-selling branded drug in pharmaceutical industry history, has delivered some confounding strategic lessons.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15

Harvard Business Review

MARCH 18, 2018

In fact, by government edict, the goal is to direct policy, health care, and even citizens themselves toward longer, healthier, more enriching lives. Why the Pharmaceutical Industry Is Booming in Japan. Everyone in Japan knows its citizenry is getting older at a faster rate than that of any other nation.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. So reducing investments in low-value care services means spending less on doctors, hospitals, and other health care technologies. rawpixel/Getty Images.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. But in the era of Big Data and decision-making at the desktop, it's vexing to think that any company with significant technology investments would allow the all-too-human traits of ownership debates and subjective opinion to override robust data analysis.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

NOVEMBER 1, 2017

While the in-person DPPs were largely successful in reducing disease risk and incidence, Duffy and James recognized that there was substantial opportunity to better scale the DPP and make it more accessible and personalized by using technology. Design the service for the patient.

Health Care 12

Health Care Participative Wireless Pharmaceuticals 12

Harvard Business Review

JUNE 22, 2016

But all assets are not created equal, especially as the technological landscape changes. Even when these firms rely on physical assets, like cars for Uber, they own the technology, not the physical asset. Digital native upstarts are gutting traditional industries one at a time, leveraging scalable technology and participative networks.

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

MARCH 12, 2012

His company is quite respected in the sustainability community both for its progressive social equity policies and for green technology that limits the environmental impacts of his company's manufacturing activities. So I asked: Do you foresee a time when you'd willingly provide access to your leading green technology to your competitors?

Co-Opetition 13

Co-Opetition Company Brandenburger Game Theory 13

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Another problem we’ve seen is that some providers, seeking to fit in to a payment cycle, focus on short-term results, losing sight of the end goals. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. But they recognize that they — and the organization — need a process to help them reach their goals.

Middle Management 14

Middle Management Six Sigma Taylorism Taylor 14

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

MAY 1, 2013

While currently crippled by inadequate infrastructure in many countries, low- and middle-income countries will be the fastest-growing markets for pharmaceuticals and medical devices over the next decade. What can the health care industry do to help fight disease, while still maintaining its commitments to shareholders? Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

SEPTEMBER 10, 2013

Corporate R&D too often focuses on refining technologies that are already in use. In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

Corporate R&D too often focuses on refining technologies that are already in use. In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

MARCH 6, 2012

Technological innovation accounted for almost half of U.S. In today's climate of intense competition, we must find ways to develop " integrative thinking " — the thinking that leads to new business ideas, especially in science and technology. Their inspiring and visionary approach helps drive business growth.

Education 11

Education Creativity How To Pharmaceuticals 11

Harvard Business Review

NOVEMBER 24, 2015

This kind of joint value is more common in computers and industrial products than in pharmaceuticals. Alcatel-Lucent is merging with Nokia to bring under one roof the internet technology of the former and the mobile communication capabilities of the latter. No, because it does not stem from added value to customers or to society.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 13, 2011

You either achieve your goals or you don't. Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago. Most organizations take the same stance.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MARCH 9, 2015

Advances in digital technology and their use in organizations carry huge promise to empower people at all levels. According to Microsoft , the goal is go beyond using scorecards and KPIs — historical views — to absorb and respond to real-time sentiments. Leadership & Managing people Technology Managing yourself'

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

SEPTEMBER 14, 2017

The belief is that at-risk pay motivates salespeople to work hard and direct effort towards sales activities that encourage achievement of sales goals. One technology company targeted a 50:50 pay mix for salespeople in new customer acquisition (CA) roles, but a 70:30 mix for salespeople in account management (AM) roles.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. The negotiators achieved their goal and closed a clever and profitable deal. PDF) But that would leave you out of the game for many new technologies and markets, where alliances are essential.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

AUGUST 29, 2011

Despite the technological prowess of India's engineers and outsourcing firms, the country's basic infrastructure isn't sophisticated enough to support telecommuting and work-from-home arrangements on a widespread basis. These stresses have serious ramifications for India's continued economic growth. We do all of them.".

Stress 14

Stress Human Resources Pharmaceuticals Sharpe 14

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. These challenges require extraordinary leaders. ” But this is changing. .”

Management 15

Management 360-Degree Feedback Mayo Training 15

Strategy Driven

MARCH 18, 2011

The goal is balance: A coherent company strikes a balance where the right product and service portfolio naturally thrives within a capabilities system consciously chosen and implemented to support a deliberate strategy or way to play. Finally, many industries are responding to the pressures of the last few years by differentiating themselves.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., And what did they say was their biggest concern? Not competitive threats. Not rising costs. chemicals, metals & mining, paper & forest products).

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

OCTOBER 23, 2017

In a project for a pharmaceutical company, we were able to isolate the specific information sources that drove positive and negative sentiment toward the client’s brand. However, when it comes to change, few track performance from project to project beyond knowing which ones met their goals. Which stakeholders are involved?

Company 8

Company Management Metrics Tools 8

Harvard Business Review

MAY 16, 2011

The end goal is clear — advanced biofuels at competitive prices from non-food sources — but the technologies to be used, the shape of future operations, and the relationships to other partners are all to be worked out in real time. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

DECEMBER 27, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). February 2013) By the People, Not For the People Maximizing Shareholder Value: The Goal That Changed Corporate America The Washington Post In 1963, IBM CEO Thomas J.

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

JUNE 12, 2018

Beacons are battery-powered wireless sensors installed in retail stores or event venues that detect nearby consumers who have opted in to alerts through Bluetooth or other technologies and that relay information to consumers’ mobile devices. Mobile technology allows firms to know where the consumer is located.

Short-term 8

Short-term Brand Long-term Media 8

Harvard Business Review

NOVEMBER 28, 2016

Today, the clinical and genetic information of cancer patients is held in a variety of places: academic medical centers, community hospitals, disease-specific foundations, pharmaceutical companies, and the government. This is one of the main goals of the HBS Kraft Accelerator. Insight Center. Innovating for Value in Health Care.

Pharmaceuticals 8

Pharmaceuticals Information Health Care Cooper 8